| Study | Country Study period |
Population source | Exposure definition | Non-exposure definition | Sample size | Rmk |
|---|---|---|---|---|---|---|
| Chan (Controls exposed to SSRIs), 2024 |
China 2003 - 2018 |
All pregnant women aged 15–50 years who gave a singleton livebirth or stillbirth (≥20 weeks of gestation) in public hospitals between January 1, 2003 and December 31, 2018. | Infants of women with prescription of Dothiepin only filled during the first trimester and prescriptions filled before pregnancy but with duration overlapping the first trimester. |
exposed to other treatment, sick
Infants of women with prescription of Selective-serotonin-reuptake-inhibitors (SSRI) only filled during the first trimester and prescriptions filled before pregnancy but with duration overlapping the first trimester. |
83 / 956 | |
| Chan (Controls unexposed, general pop), 2024 |
China 2003 - 2018 |
All pregnant women aged 15–50 years who gave a singleton livebirth or stillbirth (≥20 weeks of gestation) in public hospitals between January 1, 2003 and December 31, 2018. | Infants of women with prescription of Dothiepin only filled during the first trimester and prescriptions filled before pregnancy but with duration overlapping the first trimester. |
unexposed (general population or NOS)
Infants of pregnant women who were not prescribed with any antidepressant within 90 days before the last menstrual period and during the first trimester. |
83 / 462377 | |
| Heuvelman, 2023 |
United Kingdom 1995 - 2017 |
Pregnancies in Clinical Practice Research Datalink (CPRD) with a history of depressive symptoms or use of antidepressants in the preceding year before pregnancy. | Women who had initiated or continued Dosulepin for the treatment of depressive symptoms during pregnancy. |
unexposed, sick
Women who did not initiate or who discontinue antidepressants during pregnancy. |
451 / 16330 | Dose–response relationships, sibling design and negative control for antidepressants use as a whole (not for the class of antidepressants). |
| Lee (Controls exposed to SSRI), 2025 |
China 2003 - 2018 |
All pregnant women aged 15–50 years who gave a singleton livebirth or stillbirth (≥20 weeks of gestation) in public hospitals in Hong Kong between January 1, 2003 and December 31, 2018. | Women filling at least one prescription of Dothiepin only during pregnancy, that is the period between the date of the last menstrual period and the date of delivery. |
exposed to other treatment, sick
Women filling at least one prescription of any selective serotonin reuptake inhibitors (SSRI) only during pregnancy, that is the period between the date of the last menstrual period and the date of delivery. |
131 / 1465 | |
| Lee (Controls unexposed, general pop), 2025 |
China 2003 - 2018 |
All pregnant women aged 15–50 years who gave a singleton livebirth or stillbirth (≥20 weeks of gestation) in public hospitals in Hong Kong between January 1, 2003 and December 31, 2018. | Women filling at least one prescription of Dothiepin only during pregnancy, that is the period between the date of the last menstrual period and the date of delivery. |
unexposed (general population or NOS)
Women who were not prescribed with any antidepressant during index pregnancy. |
131 / 463440 |
| Study | Country Study period |
Case | Control | Sample size | Rmk |
|---|